Teikoku Pharma Usa Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Teikoku Pharma Usa

Access the complete profile.

Teikoku Pharma Usa Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	1718 Ringwood Avenue San Jose, CA 95131

Note: Revenues for privately held companies are statistical evaluations.


Teikoku Pharma Usa's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Teikoku Pharma Usa's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Teikoku Pharma Usa is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Teikoku Pharma Usa Annual Revenue and Growth Rate

Teikoku Pharma Usa	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Teikoku Pharma Usa's revenues are gauged from an analysis of company filings.

Teikoku Pharma Usa's Income Statement (based on Industry Averages)

Teikoku Pharma Usa P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Teikoku Pharma Usa is developing and marketing. Teikoku Pharma Usa doesn't have any recent trademark applications, indicating Teikoku Pharma Usa is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
DEXYDERM Transdermal patches for use in the treatment of attention deficit hyperactivity disorder, anxiety insomnia, or withdrawal syndromes; transdermal patches for use in the management of pain; and transdermal patches for use in providing sedation; Pharmaceutical preparations, namely, topical preparations for use in the treatment of attention deficit hyperactivity disorder; Pharmaceutical preparations, namely, topical preparations for use in the treatment of anxiety; Pharmaceutical preparations, namely, topical preparations for use in the treatment of insomnia; Pharmaceutical preparations, namely, topical preparations for use in the treatment of withdrawal syndromes; topical preparations for use in the management of pain; and topical preparations for use in providing sedation	05/20/2015
DEXMDERM Transdermal patches for use in the treatment of attention deficit hyperactivity disorder, anxiety insomnia, or withdrawal syndromes; transdermal patches for use in the management of pain; and transdermal patches for use in providing sedation; Pharmaceutical preparations, namely, topical preparations for use in the treatment of attention deficit hyperactivity disorder; Pharmaceutical preparations, namely, topical preparations for use in the treatment of anxiety; Pharmaceutical preparations, namely, topical preparations for use in the treatment of insomnia; Pharmaceutical preparations, namely, topical preparations for use in the treatment of withdrawal syndromes; topical preparations for use in the management of pain; and topical preparations for use in providing sedation	05/20/2015
DEXY PATCH Transdermal patches for use in the treatment of attention deficit hyperactivity disorder, anxiety insomnia, or withdrawal syndromes; transdermal patches for use in the management of pain; and transdermal patches for use in providing sedation; Pharmaceutical preparations, namely, topical preparations for use in the treatment of attention deficit hyperactivity disorder; Pharmaceutical preparations, namely, topical preparations for use in the treatment of anxiety; Pharmaceutical preparations, namely, topical preparations for use in the treatment of insomnia; Pharmaceutical preparations, namely, topical preparations for use in the treatment of withdrawal syndromes; topical preparations for use in the management of pain; and topical preparations for use in providing sedation	05/20/2015

See all trademarks and details in the Full Report.

Market Share of Teikoku Pharma Usa's Largest Competitors

A competitive analysis shows these companies are in the same general field as Teikoku Pharma Usa, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Teikoku Pharma Usa. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
K-M INDUSTRIES HOLDING	San Carlos, CA	100
LUMENTUM OPERATIONS	San Jose, CA	65
LYTEN	San Jose, CA	26
TAKARA BIO USA	San Jose, CA	18
TEIKOKU PHARMA USA	San Jose, CA	2
CADE	San Jose, CA	1
DECON SPECIALIST	San Jose, CA	1
ISLAND EQUIPMENT	San Jose, CA	0
CHEMICAL SAFETY TECHNOLOGY	San Jose, CA	0

Future Competition: Teikoku Pharma Usa's Fastest Growing Competitors

These companies are in the same general field as Teikoku Pharma Usa and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)